JCJ. Alexander Clark

J. Alexander Clark

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


J. Alexander Clark has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Fast-relaxing cardiomyocytes exert a dominant role in the relaxation behavior of heterogeneous myocardium

    by J. Alexander Clark, Lorenzo R. Sewanan, Jonas Schwan, Jonathan Kluger, Kenneth S. Campbell, Stuart G. Campbell


  • Open Access

    A Microwell Cell Capture Device Reveals Variable Response to Dobutamine in Isolated Cardiomyocytes

    by J. Alexander Clark, Jonathan D. Weiss, Stuart G. Campbell


  • Open Access

    A microwell cell capture device reveals variable response to dobutamine in isolated cardiomyocytes

    by J. A. Clark, J. D. Weiss, S. G. Campbell

    Isolated ventricular cardiomyocytes exhibit substantial cell-to-cell variability, even when obtained from the same small volume of myocardium. In this study, we investigated the possibility that cardiomyocyte responses to β -adrenergic stimulus are also highly heterogeneous. In order to achieve the throughput and measurement duration desired for these experiments, we designed and validated a novel microwell system that immobilizes and uniformly orients isolated adult cardiomyocytes. In this configuration, detailed drug responses of dozens of cells can be followed in parallel for intervals exceeding one hour. At the conclusion of an experiment, specific cells can also be harvested via a precision aspirator for single-cell gene expression profiling. Using this system, we followed changes in Ca 2+ signaling and contractility of individual cells under sustained application of either dobutamine or omecamtiv mecarbil. Both compounds increased average cardiomyocyte contractility over the course of an hour, but responses of individual cells to dobutamine were significantly more variable. Surprisingly, some dobutamine-treated cardiomyocytes augmented Ca 2+ release without increasing contractility. Other cells responded with increased contractility in spite of unchanged Ca 2+ release. Single-cell gene expression analysis revealed a significant correlation between expression of PRKACA and cellular sensitivity to dobutamine, demonstrating that variable drug responses among cells are not merely experimental artifacts. By enabling direct comparison of the functional behavior of an individual cell and the genes it expresses, this new system constitutes a unique tool for interrogating cardiomyocyte drug responses and discovering the genes that modulate them. SIGNIFICANCE: We have created a microwell capture device that allows drug responses of dozens of isolated adult cardiomyocytes to be monitored for extended intervals. Using the device, we observed striking diversity in the Ca 2+ handling and contractility responses of each cell to a β -adrenergic agonist. This included cells that responded to dobutamine by doubling the amplitude of Ca 2+ release while decreasing contractility and vice-versa. We further show that these diverse responses can be linked to gene expression differences between cells. This work demonstrates the feasibility of linking the drug responses of individual cells with their gene expression. It opens the possibility of exploiting cell-to-cell variation to discover new genes that participate in and modulate regulatory cascades.


  • Diverse relaxation rates exist among rat cardiomyocytes isolated from a single myocardial region

    by J. Alexander Clark, Stuart G. Campbell

    Key points: Prior studies have shown variation in the functional properties of cardiomyocytes isolated from different regions of the left ventricular myocardium. We found that these region‐dependent variations vanish below a tissue volume of ∼7 mm3 in the adult rat myocardium, revealing a fixed level of intrinsic relaxation rate heterogeneity that is independent of tissue volume. Within these microscopically varying cell populations, fast‐relaxing cells were shown to have elevated phosphorylated troponin I compared to slow‐relaxing cells. Relaxation rate was also correlated with cardiomyocyte length, in that slow‐relaxing cells were longer than fast‐relaxing cells. These results show a new relationship between cardiomyocyte morphology and myofilament relaxation, and suggest that functional diversity among individual myocytes at the microscale may contribute to bulk relaxation of the myocardium. The mean contractility and calcium handling properties of cardiomyocytes isolated from different regions of the ventricular myocardium are known to vary significantly. We designed experiments to quantify the variance in contractile properties among cells within the same myocardial region. Longitudinal strips of myocardial tissue were excised from the epicardial left ventricular free walls of adult Sprague–Dawley rats and then treated with collagenase to isolate individual myocytes. Cardiomyocytes were characterized by measuring sarcomere length changes and calcium transients during electrical pacing. Variance of the time from peak sarcomere shortening to 50% re‐lengthening (RT50) was assessed in each cell population. Isolating cells from progressively shorter strips allowed an estimate of the myocardial volume below which regional variation vanished and only microscale heterogeneity remained (∼7 mm3). The SD of RT50 within this myocardial volume was 28% of the mean. In a series of follow‐up experiments, RT50 was shown to correlate significantly with resting myocyte length, suggesting a connection between cell morphology and intrinsic relaxation behaviour. To explore the mechanistic basis of varying RT50, a novel single‐cell aspirator was employed to collect small batches of cardiomyocytes grouped according to their relaxation rates (fast or slow). Western blot analysis of the two groups revealed significantly elevated troponin I phosphorylation in fast‐relaxing cells. Our observations suggest that cell‐to‐cell heterogeneity of active contractile properties is substantial, with implications for how we understand myocardial relaxation and design drug therapies intended to alter relaxation rate.